COLL COLLEGIUM PHARMACEUTICAL INC Management Changes 8-K Filing 2024 - Management Change Joseph Ciaffoni will step down as the President and CEO of Collegium Pharmaceutical, Inc., effective May 24, 2024, and Michael Heffernan will serve as Interim President and CEO until a new CEO is appointed.Get access to all SEC 8-K filings of the COLLEGIUM PHARMACEUTICAL INC